Adjuvant immunotherapy versus observation after neoadjuvant therapy and esophagectomy for esophageal cancer with residual pathologic disease: a systematic review and reconstructed individual participant data meta-analysis.
Journal: Frontiers in immunology
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
He H, Zhang H, Lv H, et al. (2026). "Adjuvant immunotherapy versus observation after neoadjuvant therapy and esophagectomy for esophageal cancer with residual pathologic disease: a systematic review and reconstructed individual participant data meta-analysis.". Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1944032